Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.

Takahiko ToyonagaTaku KobayashiMasaru NakanoEiko SaitoSatoko UmedaShinji OkabayashiRyo OzakiToshifumi Hibi

Published in: PloS one (2017)

PRO2 predicted the short-term outcomes of remission induction treatment earlier than FC possibly because of the wide within-day variability of FC in active UC.

Keyphrases

ulcerative colitis
patient reported outcomes
disease activity
rheumatoid arthritis
anti inflammatory
combination therapy
psychometric properties